Ryman Healthcare Ltd Financials

Market Capitalization €1.23 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	9.35
Forward PE
Price to Sales TTM	€1.62
Price to Book MRQ	€0.28
Enterprise to Revenue	3.73
Enterprise to EBITDA	-524.16

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2025-03-31
Most Recent Quarter	2025-03-31
Profit Margin	-57.54%
Operating Margin	-9.73%
Return on Assets TTM	-0.21%
Return on Equity TTM	-10.91%

Income Statement

Revenue TTM	€390,544,344
Revenue per Share TTM	€1.07
Quarterly Revenue Growth	10.90%
Gross Profit TTM	€4,152,045
EBITDA	€145,786,000
Net Income to Common TTM	€-224,723,343
Diluted EPS TTM	€-0.32
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	€9,796,480
Total Cash per Share MRQ	€0.02
Total Debt MRQ	€
Total Debt to Equity MRQ	40.14
Current Ratio MRQ	0.04
Book Value per Share MRQ	€4.20

Cash Flow

Operating Cash Flow TTM	€211,049,001
Levered Free Cash Flow TTM	€154,530,055

RH7 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	1,015,713,000
Float Shares	987,057,857
Avg 10 Volume	4,378
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	14.05%
% Held by Institutions	25.74%

Stock Price Summary

Beta	0.30
Fifty Two Week Low	€1.04
Fifty Two Week High	€2.84
Fifty Two Week Change	-75.24%
Day 50 MA	€1.17
Day 200 MA	€1.93

Dividends and Splits

Forward Annual Dividend Rate	€0.27
Forward Annual Dividend Yield	23.22%
Trailing Annual Dividend Rate	€0.07
Trailing Annual Dividend Yield	5.81%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2022-12-08
Last Split Factor
Last Split Date